Eyenovia (EYEN) Revenue & Revenue Breakdown
Eyenovia Revenue Highlights
Latest Revenue (Y)
$3.79K
Latest Revenue (Q)
$1.63K
Eyenovia Revenue by Period
Eyenovia Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $3.79K | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2021-12-31 | $14.00M | 600.00% |
| 2020-12-31 | $2.00M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | - |
Eyenovia generated $3.79K in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Eyenovia Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $1.63K | -92.82% |
| 2024-06-30 | $22.63K | 353.13% |
| 2024-03-31 | $4.99K | 92.85% |
| 2023-12-31 | $2.59K | 116.11% |
| 2023-09-30 | $1.20K | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $10.00M | 100.00% |
| 2021-09-30 | - | -100.00% |
| 2021-06-30 | $2.00M | - |
| 2021-03-31 | $2.00M | - |
| 2020-12-31 | $2.00M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | - |
Eyenovia generated $1.63K in revenue during Q3 2024, up -92.82% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Eyenovia Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MCRB | Seres Therapeutics | $126.33M | - |
| ARDX | Ardelyx | $124.46M | $98.24M |
| CDTX | Cidara Therapeutics | $63.91M | - |
| FBIO | Fortress Biotech | $59.66M | $14.63M |
| OCUL | Ocular Therapeutix | $58.44M | $14.71M |
| BLRX | BioLineRx | $4.80M | $6.86M |
| IMMP | Immutep | $3.51M | $2.11M |
| LXRX | Lexicon Pharmaceuticals | $1.20M | $1.74M |
| IBRX | ImmunityBio | $622.00K | $1.05M |
| EYEN | Eyenovia | $3.79K | $1.63K |
| RVPH | Reviva Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| CGTX | Cognition Therapeutics | - | - |
| DRTS | Alpha Tau Medical | - | - |
| KOD | Kodiak Sciences | - | - |
| AVXL | Anavex Life Sciences | - | - |
| GLSI | Greenwich LifeSciences | - | - |
| RNAZ | TransCode Therapeutics | - | - |
| TNYA | Tenaya Therapeutics | - | - |